Prognostic value of
Journal
Hellenic journal of nuclear medicine
ISSN: 1790-5427
Titre abrégé: Hell J Nucl Med
Pays: Greece
ID NLM: 101257471
Informations de publication
Date de publication:
Historique:
received:
25
12
2018
accepted:
23
01
2019
pubmed:
8
3
2019
medline:
25
7
2019
entrez:
8
3
2019
Statut:
ppublish
Résumé
To investigate the prognostic value of pretreatment fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography ( Eighty-three patients who had a tumor larger than 2cm shown by Median overall follow-up was 36.3 months (16.1-76.9 months), during which 11 patients had recurrence and 4 died. Results of receiver operating characteristics curve analysis and log-rank tests showed that high primary tumor SUVmax (≥6.20), MTV (≥5.39), TLG (≥23.23), and total choline peak (≥12.1) values indicated significantly worse RFS as compared to lower values (<6.20, <5.39, <23.23, <12.1, respectively) (P=0.0085, P=0.0029, P=0.013, P=0.016, respectively). The ADC cut-off value (0.833×10 Fluorine-18-FDG PET/CT was superior as compared to MRS and DWI for determining recurrence and death prognostic factors, especially primary tumor SUVmax and TLG, in patients with breast cancer.
Identifiants
pubmed: 30843007
pii: s002449910956
doi: 10.1967/s002449910956
doi:
Substances chimiques
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Comparative Study
Evaluation Study
Journal Article
Langues
eng